Investor Contact

Hayden IR
15879 N. 80th Street
2nd Floor
Scottsdale, AZ 85260

Brett Maas
brett@haydenir.com
(646) 536-7331

Investor Relations
Heska Corporation (NASDAQ: HSKA) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Heska Corporation is traded on the NASDAQ under the ticker symbol HSKA.

Overview
Heska Corporation sells advanced veterinary diagnostic and other specialty veterinary products. Heska’s state-of-the-art offerings to its customers include blood testing instruments and supplies, digital imaging products, software and services, and single use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The Company’s core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.

EVENTS
Second Quarter 2017 Earnings Call

HSKA
NASDAQ

VOLUME
CHANGE
Optimization WordPress Plugins & Solutions by W3 EDGE